Canlyniadau Chwilio - Christi J. van Asperen

Mireinio'r Canlyniadau
  1. 1
    Cancer risks in BRCA2 families: estimates for sites other than breast and ovary

    Cancer risks in BRCA2 families: estimates for sites other than breast and ovary gan Christi J. van Asperen

    Cyhoeddwyd 2005
    Cael y testun llawn Cael y testun llawn
    Carta
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    The counsellees' view of an unclassified variant in BRCA1/2: recall, interpretation, and impact on life

    The counsellees' view of an unclassified variant in BRCA1/2: recall, interpretation, and impact on life gan Joël Vos, Wilma Otten, Christi J. van Asperen, Anna Jansen, Fred H. Menko, Aad Tibben

    Cyhoeddwyd 2007
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    A whisper-game perspective on the family communication of DNA-test results: a retrospective study on the communication process of BRCA1/2-test results between proband and relatives

    A whisper-game perspective on the family communication of DNA-test results: a retrospective study on the communication process of BRCA1/2-test results between proband and relatives gan Joël Vos, Fred H. Menko, Anna M. Jansen, Christi J. van Asperen, Anne M. Stiggelbout, Aad Tibben

    Cyhoeddwyd 2010
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Clinical Characteristics Affect the Impact of an Uninformative DNA Test Result: The Course of Worry and Distress Experienced by Women Who Apply for Genetic Testing for Breast Cancer

    Clinical Characteristics Affect the Impact of an Uninformative DNA Test Result: The Course of Worry and Distress Experienced by Women Who Apply for Genetic Testing for Breast Cance... gan Sandra van Dijk, Daniëlle R. M. Timmermans, Hanne Meijers-Heijboer, Aad Tibben, Christi J. van Asperen, Wilma Otten

    Cyhoeddwyd 2006
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Genetic testing for familial/hereditary breast cancer—comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany

    Genetic testing for familial/hereditary breast cancer—comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany gan Dorothea Gadzicki, D. Gareth Evans, Hilary Harris, Claire Julian‐Reynier, Irmgard Nippert, Jörg Schmidtke, Aad Tibben, Christi J. van Asperen, Brigitte Schlegelberger

    Cyhoeddwyd 2011
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Next-Generation Diagnostics: Gene Panel, Exome, or Whole Genome?

    Next-Generation Diagnostics: Gene Panel, Exome, or Whole Genome? gan Yu Sun, Claudia Ruivenkamp, Mariëtte J.V. Hoffer, Terry Vrijenhoek, Marjolein Kriek, Christi J. van Asperen, Johan T. den Dunnen, Gijs W.E. Santen

    Cyhoeddwyd 2015
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Genetic counseling for hereditary cancer: A pilot study on experiences of patients and family members

    Genetic counseling for hereditary cancer: A pilot study on experiences of patients and family members gan Eveline M. A. Bleiker, Neil K. Aaronson, Fred H. Menko, Daniela Hahn, Christi J. van Asperen, Emiel J. Rutgers, Leo P. ten Kate, N. J. Leschot

    Cyhoeddwyd 1997
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    The functional impact of variants of uncertain significance in BRCA2

    The functional impact of variants of uncertain significance in BRCA2 gan Romy L.S. Mesman, Fabienne M.G.R. Calléja, Giel Hendriks, Bruno Morolli, Branislav Mišovic, Peter Devilee, Christi J. van Asperen, Harry Vrieling, Maaike P.G. Vreeswijk

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Intronic variants in<i>BRCA1</i>and<i>BRCA2</i>that affect RNA splicing can be reliably selected by splice-site prediction programs

    Intronic variants in<i>BRCA1</i>and<i>BRCA2</i>that affect RNA splicing can be reliably selected by splice-site prediction programs gan Maaike P.G. Vreeswijk, Jaco Kraan, Heleen M. van der Klift, Geraldine R. Vink, Cees J. Cornelisse, Juul Wijnen, Egbert Bakker, Christi J. van Asperen, Peter Devilee

    Cyhoeddwyd 2008
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Recommendations for reporting results of diagnostic genomic testing

    Recommendations for reporting results of diagnostic genomic testing gan Zandra C. Deans, Joo Wook Ahn, Isabel M. Carreira, Elisabeth Dequeker, Mick Henderson, Luca Lovrečić, Katrin Õunap, Melody Tabiner, Rebecca J. L. Treacy, Christi J. van Asperen

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers

    Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers gan T.C. van Sprundel, Marjanka K. Schmidt, Matti A. Rookus, Richard M. Brohet, Christi J. van Asperen, Emiel J. Rutgers, Laura J. vanʼt Veer, Rob A.�E.�M. Tollenaar

    Cyhoeddwyd 2005
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Effectiveness and cost-effectiveness of meaning-centered group psychotherapy in cancer survivors: protocol of a randomized controlled trial

    Effectiveness and cost-effectiveness of meaning-centered group psychotherapy in cancer survivors: protocol of a randomized controlled trial gan Nadia van der Spek, Joël Vos, Cornelia F. van Uden–Kraan, William Breitbart, Pim Cuijpers, Kitty Knipscheer-Kuipers, Vincent Willemsen, Rob A.�E.�M. Tollenaar, Christi J. van Asperen, Irma M. Verdonck‐de Leeuw

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-<i>BRCA1/2</i>breast cancer families

    Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-<i>BRCA1/2</i>breast cancer families gan Inge M. M. Lakeman, Florentine Hilbers, Mar Rodríguez‐Girondo, Andrew Lee, Maaike P.G. Vreeswijk, Antoinette Hollestelle, Caroline Seynaeve, Hanne Meijers‐Heijboer, Jan C. Oosterwijk, Nicoline Hoogerbrugge, Edith Oláh, Hans F. A. Vasen, Christi J. van Asperen, Peter Devilee

    Cyhoeddwyd 2019
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Pathological characterisation of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program

    Pathological characterisation of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program gan Marijn A. Vermeulen, Leen Slaets, Fátima Cardoso, Sharon H. Giordano, Konstantinos Tryfonidis, P. J. van Diest, N Dijkstra, Carolien P. Schröder, Christi J. van Asperen, Barbro Linderholm, Kim Benstead, Renée Foekens, John W.M. Martens, John M.S. Bartlett, Carolien H. M. van Deurzen

    Cyhoeddwyd 2017
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases

    Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases gan Petra E.A. Huijts, Maaike P.G. Vreeswijk, Karin Kroeze‐Jansema, Catharina E. Jacobi, Caroline Seynaeve, Elly MM Krol-Warmerdam, Pauline M. Wijers‐Koster, Jannet Blom, Karen A. Pooley, Jan G.M. Klijn, Rob A.�E.�M. Tollenaar, Peter Devilee, Christi J. van Asperen

    Cyhoeddwyd 2007
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    A Genotypic and Histopathological Study of a Large Dutch Kindred with Hyperparathyroidism-Jaw Tumor Syndrome1

    A Genotypic and Histopathological Study of a Large Dutch Kindred with Hyperparathyroidism-Jaw Tumor Syndrome1 gan Carola J. Haven, Fung Ki Wong, Eveline W. C. M. van Dam, Rob B. van der Luijt, Christi J. van Asperen, Joke Jansen, Carla Rosenberg, Mireille de Wit, Janine Roijers, Jo W.M. Höppener, Cornelis J.M. Lips, Catharina Larsson, Bin Tean Teh, Hans Morreau

    Cyhoeddwyd 2000
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers

    Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers gan Anouk Pijpe, Peggy Manders, Richard M. Brohet, J. Margriet Collée, Senno Verhoef, Hans F. A. Vasen, Nicoline Hoogerbrugge, Christi J. van Asperen, Charlotte J. Dommering, Margreet G.E.M. Ausems, Cora M. Aalfs, E. Gómez, Laura J. vanʼt Veer, Flora E. van Leeuwen, Matti A. Rookus

    Cyhoeddwyd 2009
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients

    Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients gan Ettore Capoluongo, Gillian Ellison, José Antonio López‐Guerrero, Frédérique Penault‐Llorca, Marjolijn J. L. Ligtenberg, Susana Banerjee, Christian F. Singer, Eitan Friedman, Birgid Markiefka, Peter Schirmacher, Reinhard Büttner, Christi J. van Asperen, Isabelle Ray‐Coquard, Volker Endris, Suzanne Kamel‐Reid, Natalie Percival, Jane Bryce, Benno Röthlisberger, Richie Soong, David González de Castro

    Cyhoeddwyd 2017
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial cases

    Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial cases gan Inge M. M. Lakeman, Mar D M Rodríguez-Girondo, Andrew Lee, Nandi Celosse, Merel E. Braspenning, Klaartje van Engelen, Irma van de Beek, Annemiek H van der Hout, E. Gómez, Arjen R. Mensenkamp, Margreet G.E.M. Ausems, Maartje J. Hooning, Muriel A. Adank, Antoinette Hollestelle, Marjanka K. Schmidt, Christi J. van Asperen, Peter Devilee

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    BRCA1 and BRCA2 genetic testing—pitfalls and recommendations for managing variants of uncertain clinical significance

    BRCA1 and BRCA2 genetic testing—pitfalls and recommendations for managing variants of uncertain clinical significance gan Diana Eccles, Gillian Mitchell, Álvaro N.A. Monteiro, Rita K. Schmutzler, Fergus J. Couch, Amanda B. Spurdle, E. Gómez, Ronald H. Driessen, Noralane M. Lindor, Marinus J. Blok, Pål Møller, Miguel de la Hoya, Tuya Pal, S. M. Domchek, Katherine L. Nathanson, Christi J. van Asperen, Orland Dı́ez, K. Rheim, Dominique Stoppa‐Lyonnet, Michael T. Parsons, David E. Goldgar

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: